Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (51-60 of 206) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Progression-free survival as a surrogate endpoint for median overall survival in metastatic colorectal cancer: literature-based analysis from 50 randomized first-line trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Partition: a surjective mapping approach for dimensionality reductionJoshua Millstein, Francesca Battaglin, Malcolm Barrett, et al.
Technology in Cancer Research & Treatment|February 8, 2014
Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot StudyChristine Schmid-Tannwald, Frederik F Strobl, Daniel Theisen, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
International Journal of Molecular Sciences|May 27, 2023
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast CancerMartin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, et al.
Oncology Research and Treatment|August 22, 2023
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN TrialsLinda Katharina Zöhrlaut, Meinolf Karthaus, Ursula Vehling-Kaiser, et al.
Acta Oncologica (Stockholm, Sweden)|July 15, 2014
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Oncotarget|August 14, 2018
The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximabMatthias F Froelich, Sebastian Stintzing, Jörg Kumbrink, et al.
Pageof 21

Showing results (51-60 of 206) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2012
Progression-free survival as a surrogate endpoint for median overall survival in metastatic colorectal cancer: literature-based analysis from 50 randomized first-line trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Bioinformatics (Oxford, England)|September 11, 2019
Partition: a surjective mapping approach for dimensionality reductionJoshua Millstein, Francesca Battaglin, Malcolm Barrett, et al.
Technology in Cancer Research & Treatment|February 8, 2014
Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot StudyChristine Schmid-Tannwald, Frederik F Strobl, Daniel Theisen, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trialDominik P Modest, Ruediger P Laubender, Sebastian Stintzing, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
International Journal of Molecular Sciences|May 27, 2023
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast CancerMartin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, et al.
Oncology Research and Treatment|August 22, 2023
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN TrialsLinda Katharina Zöhrlaut, Meinolf Karthaus, Ursula Vehling-Kaiser, et al.
Acta Oncologica (Stockholm, Sweden)|July 15, 2014
Surrogate endpoints in second-line treatment for mCRC: a systematic literature-based analysis from 23 randomised trialsClemens Giessen, Ruediger Paul Laubender, Donna Pauler Ankerst, et al.
Oncotarget|August 14, 2018
The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximabMatthias F Froelich, Sebastian Stintzing, Jörg Kumbrink, et al.
Pageof 21